Share
|
Copy Link
https://eyewire.news/tv/eyewire-tv-march-3rd-2021
https://eyewire.news/tv/allergan-submits-nda-to-the-fda-for-investigational-eye-drop-for-presbyopia
https://eyewire.news/tv/glaukos-announces-positive-phase-3-results-for-ilink-epi-on-investigational-therapy
https://eyewire.news/tv/iridex-and-topcon-partner-in-strategic-sale-and-distribution-collaboration
https://eyewire.news/tv/fda-approves-nda-filings-for-two-novel-ophthalmic-products